Expertise in
9
conditions

Christian Buske

Albert Einstein Allee 11, 
Ulm, BW, DE 
Expertise in
9
conditions
Albert Einstein Allee 11, 
Ulm, BW, DE 

Overview

Christian Buske practices practicing medicine in Ulm, Germany.

Mr. Buske is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Waldenstrom Macroglobulinemia, Follicular Lymphoma, Non-Hodgkin Lymphoma, Tissue Biopsy, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 169 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Albert Einstein Allee 11, Ulm, BW 89081, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Obinutuzumab in Marginal Zone Lymphoma (OLYMP-1)
Obinutuzumab in Marginal Zone Lymphoma (OLYMP-1)
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug
Study Drug: Obinutuzumab
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug
Study Drugs: BGB-3111 (Zanubrutinib), Ibrutinib
Study Phase: Phase 3
Efficacy of First Line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Efficacy of First Line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Enrollment Status: Completed
Publish Date: May 13, 2024
Intervention Type: Drug
Study Drugs: Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
Study Phase: Phase 3
View 2 Less Clinical Trials

169 Total Publications

Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data.
Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data.
Journal: Annals of hematology
Published: December 10, 2025

Frequently Asked Questions about Christian Buske

Is Christian Buske a top-rated expert for Waldenstrom Macroglobulinemia?

MediFind is an objective health platform that identifies experts based on real-world data. Christian Buske is classified as an Elite expert for Waldenstrom Macroglobulinemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christian Buske participate in research or clinical trials?

Yes. Christian Buske has published 169 articles and abstracts on conditions like Waldenstrom Macroglobulinemia. You can view a list of Christian Buske's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Buske's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile